APA (7th ed.) Citation

Campone, M., Bachelot, T., Treilleux, I., Pistilli, B., Salleron, J., Seegers, V., . . . Merlin, J. (2021). A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). European Journal of Cancer, 158, 169. https://doi.org/10.1016/j.ejca.2021.09.017

Chicago Style (17th ed.) Citation

Campone, Mario, et al. "A Phase II Randomised Study of Preoperative Trastuzumab Alone or Combined with Everolimus in Patients with Early HER2-positive Breast Cancer and Predictive Biomarkers (RADHER Trial)." European Journal of Cancer 158 (2021): 169. https://doi.org/10.1016/j.ejca.2021.09.017.

MLA (9th ed.) Citation

Campone, Mario, et al. "A Phase II Randomised Study of Preoperative Trastuzumab Alone or Combined with Everolimus in Patients with Early HER2-positive Breast Cancer and Predictive Biomarkers (RADHER Trial)." European Journal of Cancer, vol. 158, 2021, p. 169, https://doi.org/10.1016/j.ejca.2021.09.017.